Literature DB >> 33729690

MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases.

Flavia Plastino1, Noemi Anna Pesce1, Helder André1.   

Abstract

Ocular neovascular diseases, such as proliferative diabetic retinopathy, retinopathy of prematurity and neovascular age-related macular degeneration, are the leading causes of visual impairment worldwide. The hypoxia-inducible factors and vascular endothelial growth factors are key molecular promoters of ocular neovascularization. Moreover, the role of microRNAs as regulators of angiogenesis has been expanding, particularly hypoxia-associated microRNA; hypoxamiRs. This review provides a summary of hypoxamiRs that directly and specifically target HIF1A and VEGF mRNAs, thus critically involved in the regulation of ocular neovascular pathologies. The discussed microRNAs highlight putative diagnostic markers and therapeutic agents in choroidal and retinal angiogenic diseases, including proliferative diabetic retinopathy, retinopathy of prematurity and neovascular age-related macular degeneration.
© 2021 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  age-related macular degeneration; angiogenesis; corneal neovascularization; hypoxamiR; proliferative diabetic retinopathy; retinopathy of prematurity

Mesh:

Substances:

Year:  2021        PMID: 33729690     DOI: 10.1111/aos.14845

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.

Authors:  Kun Zhao; Yaping Jiang; Jing Zhang; Jing Shi; Pengxiang Zheng; Chuanxi Yang; Yihui Chen
Journal:  Cell Cycle       Date:  2022-06-13       Impact factor: 5.173

Review 2.  Application Progress of High-Throughput Sequencing in Ocular Diseases.

Authors:  Xuejun He; Ningzhi Zhang; Wenye Cao; Yiqiao Xing; Ning Yang
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

3.  Network-based inference of master regulators in epithelial membrane protein 2-treated human RPE cells.

Authors:  Hua Wan; Wei Gao; Wei Zhang; Zijiao Tao; Xiang Lu; Feng Chen; Jian Qin
Journal:  BMC Genom Data       Date:  2022-07-07

4.  MiR-375 mitigates retinal angiogenesis by depressing the JAK2/STAT3 pathway.

Authors:  Ruowen Gong; Ruyi Han; Xiaonan Zhuang; Wenyi Tang; Gezhi Xu; Lei Zhang; Jihong Wu; Jun Ma
Journal:  Aging (Albany NY)       Date:  2022-08-17       Impact factor: 5.955

Review 5.  Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches.

Authors:  Matthias W Laschke; Yuan Gu; Michael D Menger
Journal:  Front Physiol       Date:  2022-08-17       Impact factor: 4.755

Review 6.  The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer.

Authors:  Chengyao Chiang; Heng Yang; Lizhi Zhu; Chunlan Chen; Cheng Chen; You Zuo; Duo Zheng
Journal:  Front Genet       Date:  2022-06-22       Impact factor: 4.772

7.  Differential expression of aqueous humor microRNAs in central retinal vein occlusion and its association with matrix metalloproteinases: a pilot study.

Authors:  Eun Hee Hong; Mina Hwang; Hyoseon Yu; Hyun-Hee Park; Heeyoon Cho; Seong-Ho Koh; Yong Un Shin
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.